Attorney General Eric Holder announced a new Drug Enforcement Administration regulation that would allow pharmacies and other authorized collectors to serve as authorized drop-off sites for unused prescription drugs.
Shortly after announcing Wednesday morning its corporate name change to CVS Health, CEO Larry Merlo appeared on CNBC to weigh in on the name change and the opportunities to play a greater role in today’s healthcare market, as well as to highlight the fact that its stores are now officially tobacco-free.
The National Association of Chain Drug Stores announced on Wednesday that it has written to the Centers for Medicare and Medicaid Services to “recommend administrative changes to facilitate a smooth start for new exchange enrollees seeking prescription drug coverage in the 2015 plan year.”
The steep decline in the use of hormone therapy has spawned a prevalent but preventable side effect: Millions of women suffering in silence with hot flashes, according to a study by a Yale School of Medicine researcher and colleagues.
With the National Association of Chain Drug Stores Total Store Expo currently underway in Boston, the Boston Globe published an op-ed in its opinion section, Podium, which was co-authored by Steven Anderson, president and CEO of NACDS and Michael Malloy, PharmD and dean of the MCPHS University School of Pharmacy - Worcester/Manchester.
Nipro Diagnostics announced that the Food and Drug Administration approved its True Metrix self-monitoring blood-glucose system, as well as the True Metrix Pro professional monitoring blood-glucose system.
The generic drug industry — and by extension, patients across the United States — is being adversely impacted by what some are calling branded drug makers’ abuse of risk evaluation and mitigation strategies, or REMS.
Despite a rocky start, the full rollout of health reform under the Affordable Care Act has already brought major benefits to the nation’s troubled health system and affordable coverage to millions of formerly uninsured or underinsured Americans, one of the Obama administration’s top health officials asserted recently.
While drug stores across North America have diversified their mix over the past few years, over-the-counter medications remain at the heart of most every pharmacy retailer’s efforts, helping to maintain the drug channel’s inherent value as a front-line healthcare provider and the outlet of choice for consumers suffering from a wide range of minor illnesses.
“We have a system that needs fixing.” That comment on the state of the nation’s healthcare system, shared by physician and New York Times correspondent and senior writer Elisabeth Rosenthal, served as the springboard for a high-level summit on the future of health care in the United States. The event drew a who’s who of nationally known health experts, scientists and government officials.
About 30% of top-performing OTC drugs today were once prescription-only medications, Dave Wendland, VP Hamacher Resource Group, noted during a videocast hosted by GMDC, titled “Rx-to-OTC: Getting it Right at Retail.”
PharmaJet, the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL, the maker of Afluria (influenza vaccine) on Tuesday announced the Food and Drug Administration has approved the PharmaJet Stratis 0.5mL Needle-Free Jet Injector for delivery of Afluria in individuals ages 18 years to 64 years.
Alliance Boots on Monday announced it has acquired full ownership of UniDrug Distribution Group, its pre-wholesale and contract logistics joint venture in the United Kingdom, from UDG Healthcare for a consideration of around £66 million ($110.4 million) for the 50% shareholding it did not already own.